Meaghan Loy, MS, ALAT, SOT Associate Member and Category Director of In Vivo Services at Scientist.com reflects on a recent 3-part webinar series focusing…

Guest blog written by antibodies-online.com CUT&RUN (Cleavage Under Targets and Release Using Nuclease) is a novel method to map genomic protein binding sites…

Guest blog written by antibodies-online.com Humans can experience bioluminescence most anywhere in nature. Perhaps the most famous animal that glows in the dark…

There are as many ways to create in vivo proposals on the Scientist.com marketplace as there are researchers to request them, so how do we ensure that all requests are being compared equally? Scientist.com has streamlined the process by enabling side-by-side comparisons of proposals across multiple vendors based on key indicators such as quality, price, supplier rating and turnaround time.

Upsetting the status quo is never easy, especially when it comes to scientific research. Just ask AstraZeneca duo Natasha A. Karp, Associate Principal Scientist/ Biostatistician and Neil Reavey, Associate Director, Research Assurance, who explore ways of overcoming the issue of sex bias in a paper entitled, “Sex Bias in Preclinical Research and Exploration of How to Change the Status Quo.”